logo
#

Latest news with #OxcarbazepineER

Top stocks to watch today, June 9: Bharat Electronics, Infosys, NTPC, RITES, Garden Reach, NHPC and more
Top stocks to watch today, June 9: Bharat Electronics, Infosys, NTPC, RITES, Garden Reach, NHPC and more

Business Upturn

time09-06-2025

  • Business
  • Business Upturn

Top stocks to watch today, June 9: Bharat Electronics, Infosys, NTPC, RITES, Garden Reach, NHPC and more

By Aman Shukla Published on June 9, 2025, 08:31 IST Benchmark indices closed sharply higher on Friday, with the BSE Sensex jumping 746.95 points and the NSE Nifty reclaiming the 25,000-mark. The rally came after the Reserve Bank of India (RBI) announced a higher-than-expected 50 basis points interest rate cut—its third consecutive reduction—and lowered the cash reserve ratio (CRR), aiming to infuse liquidity and support growth amid global uncertainties. As markets open on June 9, several stocks are expected to remain in focus due to recent announcements and developments. Here's a list of key stocks to watch: Key Stocks to Watch Bharat Electronics Ltd (BEL): Signed a memorandum of understanding with Tata Electronics to explore collaboration opportunities in the semiconductor space. Infosys: Received closure from the Directorate General of GST Intelligence on a pre-show cause notice amounting to ₹32,403 crore. NTPC: Declared 193 MW of the 245 MW capacity at its Nokh Solar Project as commercially operational. Power Grid Corporation: Commissioned a fibre optic communication system in the Western region. UPL: Its subsidiary Advanta Seeds Brazil will sell the assets of associate company Serra Bonita for $125 million. Multi Commodity Exchange (MCX): Received SEBI approval to launch electricity derivatives. Mahanagar Gas Ltd (MGL): Stated preference for volume over margin, projects 10%+ volume CAGR over the next 2–3 years. NHPC: Completed Phase 3 of its 300 MW solar project, adding 53.6 MW capacity. RITES: Entered into an MoU with Hindustan Copper for critical mineral supply chain initiatives in India and overseas. Garden Reach Shipbuilders: Signed MoUs in Sweden and Denmark focusing on marine systems and the cruise segment. Afcons Infrastructure: Received a letter of award worth ₹700 crore from Reliance Industries. RailTel: Secured orders totalling ₹258 crore. PNC Infratech: Received a letter of intent for an EPC project worth ₹240 crore from Rajasthan PWD. SPML Infra: Maharashtra government allotted 99,000 sq. m. of land for a battery energy storage systems manufacturing unit. Lupin: Received tentative approval from the US FDA for Oxcarbazepine ER tablets used to control seizures. Asian Paints: The Competition Commission of India (CCI) is expected to issue an order soon in an abuse of dominance probe following a complaint by Birla Opus. Suzlon Energy: Promoters may sell up to 20 crore shares via block deals at a 2.9% discount to the current market price. Ambuja Cements & Nuvoco Vistas: The West Bengal government has revoked an earlier incentive scheme. Dalmia Bharat & Star Cement: Also affected by the West Bengal government's withdrawal of incentive schemes. Disclaimer: The information provided is for informational purposes only and should not be considered financial or investment advice. Stock market investments are subject to market risks. Always conduct your own research or consult a financial advisor before making investment decisions. Author or Business Upturn is not liable for any losses arising from the use of this information. Bharat ElectronicsGarden ReachInfosysNHPCNTPCRITESStock Market Aman Shukla is a post-graduate in mass communication . A media enthusiast who has a strong hold on communication ,content writing and copy writing. Aman is currently working as journalist at

Stocks in focus today: BEL, UPL, Infosys, NTPC, Lupin, KEI, L&T ESG bond, Suzlon stake sale reports among key stocks to watch
Stocks in focus today: BEL, UPL, Infosys, NTPC, Lupin, KEI, L&T ESG bond, Suzlon stake sale reports among key stocks to watch

Business Upturn

time09-06-2025

  • Business
  • Business Upturn

Stocks in focus today: BEL, UPL, Infosys, NTPC, Lupin, KEI, L&T ESG bond, Suzlon stake sale reports among key stocks to watch

By News Desk Published on June 9, 2025, 08:02 IST Indian equities are likely to track a busy news flow on Monday with several key corporate announcements, regulatory approvals, MoUs, credit updates, and sector developments in focus. Among the notable corporate updates, Bharat Electronics and Tata Electronics signed an MoU to advance India's self-reliance in electronics and semiconductors, while UPL announced the sale of Serra Bonita assets in Brazil for $125 million. GHV Infra received a road construction order worth Rs 546 crore in Mumbai, and KEI Industries saw a credit rating upgrade to IND AA+ with stable outlook from India Ratings. Azad Engineering saw Nomura buying a stake worth Rs 66 crore in a block deal, and Tata Communications announced a new subsea cable project linking Singapore, Hong Kong, and Japan to boost connectivity. In other deals, Panorama Studios signed a 5-year exclusive airborne rights agreement with Digital 18 Media for 50 Hindi films, while a Kernex/KEC consortium secured a Rs 182.81 crore contract from Western Railways for KAVACH 4.0 installation. IDFC First Bank gained after CCI allowed Warburg Pincus to acquire up to 10% in the bank. Afcons received a Rs 700 crore order from Reliance Industries. Among pharma names, Lupin secured tentative USFDA approval for Oxcarbazepine ER tablets, while Nazara Technologies acquired Smaaash Entertainment for Rs 126 crore. Infosys also got closure from GST Intelligence on a Rs 32,403 crore pre-show cause notice, while NTPC started commercial operations of its 250 MW Tehri PSP unit. Meanwhile, NOCIL and Yasho Industries will be in focus after India imposed anti-dumping duties on certain imports from China, Japan, and the EU. In other sectoral news, Jefferies remains bullish on Indian cement, expecting a pricing recovery in Q1 and profitability turnaround in FY26, with UltraTech, Shree Cement, and JK Cement as top picks. M&M reported a 28% YoY rise in May production, while Hindustan Copper and RITES signed an MoU for establishing a sustainable metal supply chain. On the neutral side, RattanIndia Power and Punjab National Bank reported key management resignations, and Bajaj Finance set June 16 as the record date for stock split and bonus shares. L&T announced a landmark Rs 500 crore ESG bond issue — the first such issuance by an Indian corporate under SEBI's new framework. Suzlon Energy could remain volatile amid reports that promoters may look to sell a significant stake via block deals. On the negative side, VIP Industries faces a commercial suit filed by Jiaxing Bianca Travel Goods in Bombay Civil Court. Dividend ex-dates today include Nelco (Rs 1/share), while Asian Paints, Indian Bank, Johnson Controls, Tata Investment, and Vesuvius India will trade ex-dividend from tomorrow. Vesuvius India will also undergo a stock split from Rs 10 to Rs 1. News desk at

Lupin gets USFDA nod for Oxcarbazepine ER tablets
Lupin gets USFDA nod for Oxcarbazepine ER tablets

Business Standard

time09-06-2025

  • Business
  • Business Standard

Lupin gets USFDA nod for Oxcarbazepine ER tablets

Lupin announced that it has received tentative approval from the U.S Food and Drug Administration (US FDA) for its abbreviated new drug application for Oxcarbazepine extended-release (ER) tablets. Oxcarbazepine ER tablets, 150 mg, 300 mg, and 600 mg are bioequivalent to Oxtellar XR ER tablets, 150 mg, 300 mg, and 600 mg, of Supernus Pharmaceuticals, Inc., and are indicated for the treatment of partial-onset seizures in patients 6 years of age and older. This product would be manufactured at Lupins Nagpur facility in India. Oxcarbazepine ER tablets (RLD Oxtellar XR) had estimated annual sales of $206 million in the U.S. (IQVIA MAT April 2025). Lupin is a global pharmaceutical leader headquartered in Mumbai, India, with products distributed in over 100 markets. It specializes in pharmaceutical products, including branded and generic formulations, complex generics, biotechnology products, and active pharmaceutical ingredients. The companys consolidated net profit surged 114.9% to Rs 772.52 crore on 13.6% jump in net sales to Rs 5,562.20 crore in Q4 FY25 over Q4 FY24. The scrip rose 0.20% to end at Rs 1,999.20 on the BSE.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store